title: Nonhomologous recombination between defective poliovirus and coxsackievirus genomes suggests a new model of genetic plasticity for picornaviruses.
abstract: Most of the circulating vaccine-derived polioviruses (cVDPVs) implicated in poliomyelitis outbreaks in Madagascar have been shown to be recombinants between the type 2 poliovirus (PV) strain of the oral polio vaccine (Sabin 2) and another species C human enterovirus (HEV-C), such as type 17 coxsackie A virus (CA17) in particular. We studied intertypic genetic exchanges between PV and non-PV HEV-C by developing a recombination model, making it possible to rescue defective type 2 PV RNA genomes with a short deletion at the 3' end by the cotransfection of cells with defective or infectious CA17 RNAs. We isolated over 200 different PV/CA17 recombinants, using murine cells expressing the human PV receptor (PVR) and selecting viruses with PV capsids. We found some homologous (H) recombinants and, mostly, nonhomologous (NH) recombinants presenting duplications of parental sequences preferentially located in the regions encoding proteins 2A, 2B, and 3A. Short duplications appeared to be stable, whereas longer duplications were excised during passaging in cultured cells or after multiplication in PVR-transgenic mice, generating H recombinants with diverse sites of recombination. This suggests that NH recombination events may be a transient, intermediate step in the generation and selection of the fittest H recombinants. In addition to the classical copy-choice mechanism of recombination thought to generate mostly H recombinants, there may also be a modular mechanism of recombination, involving NH recombinant precursors, shaping the genomes of recombinant enteroviruses and other picornaviruses. Importance: The multiplication of circulating vaccine-derived polioviruses (cVDPVs) in poorly immunized human populations can render these viruses pathogenic, causing poliomyelitis outbreaks. Most cVDPVs are intertypic recombinants between a poliovirus (PV) strain and another human enterovirus, such as type 17 coxsackie A viruses (CA17). For further studies of the genetic exchanges between PV and CA17, we have developed a model of recombination, making it possible to rescue defective PV RNA genomes with a short deletion by cotransfecting cells with the defective PV genome and CA17 genomic RNA. Numerous recombinants were found, including homologous PV/CA17 recombinants, but mostly nonhomologous recombinants presenting duplications of parental sequences preferentially located in particular regions. Long duplications were excised by passages in cultured cells or in mice, generating diverse homologous recombinants. Recombination leading to nonhomologous recombinants, which evolve into homologous recombinants, may therefore be seen as a model of genetic plasticity in enteroviruses and, possibly, in other RNA viruses.
authors.forename: Barbara
authors.initials: B
authors.lastname: Holmblat
authors.affiliation: Institut Pasteur, Biologie des Virus Entériques, Paris, France INSERM U994, Institut National de La Santé et de La Recherche Médicale, Paris, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Jégouic
authors.forename: Claire
authors.initials: C
authors.lastname: Muslin
authors.forename: Bruno
authors.initials: B
authors.lastname: Blondel
authors.forename: Marie-Line
authors.initials: ML
authors.lastname: Joffret
authors.affiliation: francis.delpeyroux@pasteur.fr.
authors.forename: Francis
authors.initials: F
authors.lastname: Delpeyroux
mesh_terms: D004770:Enterovirus / Q000235:genetics*; D016679:Genome, Viral / Q000235:genetics*; D010849:Picornaviridae / Q000235:genetics*; D017955:Poliovirus / Q000235:genetics*; D011995:Recombination, Genetic / Q000235:genetics
references.citation: J Virol. 2002 Nov;76(21):10921-8
references.pmid: 12368335
references.citation: J Virol. 1995 Dec;69(12):7391-401
references.pmid: 7494243
references.citation: Virology. 1992 Nov;191(1):309-20
references.pmid: 1329322
references.citation: Science. 2002 Apr 12;296(5566):356-9
references.pmid: 11896235
references.citation: J Virol. 2006 Nov;80(22):11124-40
references.pmid: 16956935
references.citation: J Virol. 2004 Dec;78(24):13512-21
references.pmid: 15564462
references.citation: J Virol. 2006 Jan;80(1):483-93
references.pmid: 16352572
references.citation: Curr Top Microbiol Immunol. 2006;299:211-59
references.pmid: 16568901
references.citation: PLoS Pathog. 2013 Feb;9(2):e1003164
references.pmid: 23408891
references.citation: PLoS Pathog. 2007 Dec;3(12):e191
references.pmid: 18085822
references.citation: J Virol. 2004 Jun;78(12):6271-81
references.pmid: 15163720
references.citation: Science. 1994 Sep 2;265(5177):1448-51
references.pmid: 8073288
references.citation: J Virol. 1999 Nov;73(11):8958-65
references.pmid: 10516001
references.citation: Proc Natl Acad Sci U S A. 2007 May 29;104(22):9457-62
references.pmid: 17517601
references.citation: Ann N Y Acad Sci. 1980;354:484-90
references.pmid: 6452848
references.citation: Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6390-4
references.pmid: 8341643
references.citation: J Infect Dis. 2008 May 15;197(10):1427-35
references.pmid: 18419577
references.citation: Virology. 2000 Dec 20;278(2):456-66
references.pmid: 11118368
references.citation: J Virol. 1998 Jan;72(1):20-31
references.pmid: 9420196
references.citation: Viruses. 2011 Aug;3(8):1460-84
references.pmid: 21994791
references.citation: J Virol. 2008 Sep;82(17):8927-32
references.pmid: 18579607
references.citation: Nucleic Acids Res. 1984 Aug 24;12(16):6587-601
references.pmid: 6089122
references.citation: Rev Med Virol. 2005 May-Jun;15(3):157-67
references.pmid: 15578739
references.citation: J Virol. 1991 Mar;65(3):1377-82
references.pmid: 1847458
references.citation: J Virol. 2013 Oct;87(20):11031-46
references.pmid: 23926333
references.citation: Adv Drug Deliv Rev. 2004 Apr 19;56(6):835-52
references.pmid: 15063593
references.citation: J Virol. 2000 Sep;74(18):8434-43
references.pmid: 10954543
references.citation: J Virol. 2001 Jul;75(13):5740-51
references.pmid: 11390576
references.citation: J Med Virol. 1991 Dec;35(4):290-6
references.pmid: 1666406
references.citation: PLoS Pathog. 2013 Mar;9(3):e1003228
references.pmid: 23555245
references.citation: J Gen Virol. 1981 Oct;56(Pt 2):337-47
references.pmid: 6273502
references.citation: Cell. 1986 Nov 7;47(3):433-43
references.pmid: 3021340
references.citation: J Infect Dis. 2012 May 1;205(9):1363-73
references.pmid: 22457288
references.citation: PLoS One. 2011;6(9):e24823
references.pmid: 21931857
references.citation: Virology. 1985 Jun;143(2):467-77
references.pmid: 2998022
references.citation: J Virol. 1994 May;68(5):3289-97
references.pmid: 8151789
references.citation: J Virol. 1994 Jun;68(6):3925-33
references.pmid: 8189529
references.citation: Emerg Infect Dis. 2003 Jul;9(7):885-7
references.pmid: 12899139
references.citation: Virology. 1993 Jan;192(1):18-26
references.pmid: 8390752
references.citation: J Virol. 2002 Sep;76(17):8920-30
references.pmid: 12163611
references.citation: J Virol. 1994 Feb;68(2):681-8
references.pmid: 8289371
references.citation: PLoS Pathog. 2009 May;5(5):e1000412
references.pmid: 19412342
references.citation: RNA. 2003 Oct;9(10):1221-31
references.pmid: 13130136
references.citation: Virology. 1986 Nov;155(1):202-13
references.pmid: 3022471